S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
This Stock Could Go Up 66% or More. (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
This Stock Could Go Up 66% or More. (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
This Stock Could Go Up 66% or More. (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
This Stock Could Go Up 66% or More. (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
This Stock Could Go Up 66% or More. (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
This Stock Could Go Up 66% or More. (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
This Stock Could Go Up 66% or More. (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
This Stock Could Go Up 66% or More. (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
This Stock Could Go Up 66% or More. (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
This Stock Could Go Up 66% or More. (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
This Stock Could Go Up 66% or More. (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
This Stock Could Go Up 66% or More. (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
NASDAQ:IMPL

Impel Pharmaceuticals (IMPL) Institutional Ownership

$0.55
+0.02 (+3.77%)
(As of 09/22/2023 ET)
Compare
Today's Range
$0.50
$0.59
50-Day Range
$0.31
$1.75
52-Week Range
$0.29
$6.31
Volume
69,239 shs
Average Volume
2.52 million shs
Market Capitalization
$13.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.67

Institutional Ownership Changes (13F Filings) for Impel Pharmaceuticals (NASDAQ:IMPL)

Current
Institutional Ownership
Percentage
73.88%
Number of
Institutional Buyers
(last 12 months)
8
Total
Institutional Inflows
(last 12 months)
$11.87 M
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$137,490.72
Get IMPL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Impel Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

IMPL Institutional Buying and Selling by Quarter


Impel Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/9/2023DCF Advisers LLC303,605$0.39M0.2%-20.8%1.278%
7/17/2023Mcdonald Partners LLC20,200$26K0.0%+72.6%0.085%
5/16/2023State Street Corp25,200$35K0.0%-32.8%0.106%
2/15/2023Jane Street Group LLC13,147$49K0.0%N/A0.055%
2/15/2023NVP Associates LLC3,077,198$11.54M11.3%N/A12.962%
2/13/2023Geode Capital Management LLC154,238$0.58M0.0%+3.8%0.650%
2/8/2023Raymond James & Associates14,500$54K0.0%N/A0.061%
1/18/2023Mcdonald Partners LLC11,700$44K0.0%N/A0.049%
11/15/2022BlackRock Inc.107,254$0.52M0.0%+10.0%0.452%
11/15/2022Citadel Advisors LLC13,217$64K0.0%N/A0.056%
11/14/2022Ergoteles LLC24,447$0.12M0.0%-13.9%0.103%
11/10/2022Tower Research Capital LLC TRC 10,245$50K0.0%+746.7%0.043%
8/18/2022Goldman Sachs Group Inc.14,285$0.13M0.0%+11.6%0.062%
8/15/2022State Street Corp41,700$0.39M0.0%-76.8%0.180%
8/15/2022Opaleye Management Inc.144,642$1.35M0.6%N/A0.624%
8/15/2022Laurion Capital Management LP124,800$1.16M0.0%N/A0.539%
8/15/2022Millennium Management LLC144,207$1.34M0.0%N/A0.622%
8/13/2022Renaissance Technologies LLC17,200$0.16M0.0%-48.2%0.074%
8/12/2022Northern Trust Corp10,220$95K0.0%-79.6%0.044%
8/11/2022DCF Advisers LLC438,566$4.09M2.4%+19.5%1.893%
6/7/2022Bank of America Corp DE14,908$95K0.0%-12.6%0.064%
5/16/2022Goldman Sachs Group Inc.12,801$82K0.0%+19.8%0.055%
5/16/2022State Street Corp180,045$1.15M0.0%+6.6%0.777%
5/13/2022Renaissance Technologies LLC33,200$0.21M0.0%N/A0.143%
5/13/2022DCF Advisers LLC367,058$2.34M1.0%+43.4%1.584%
5/13/2022Vanguard Group Inc.531,784$3.39M0.0%+8.1%2.295%
5/12/2022BlackRock Inc.345,672$2.20M0.0%-2.6%1.492%
5/9/2022Qube Research & Technologies Ltd11,867$76K0.0%-41.7%0.051%
2/14/2022Point72 Hong Kong Ltd5,864$51K0.0%N/A0.025%
2/14/2022Point72 Asset Management L.P.208,760$1.80M0.0%N/A0.906%
2/10/2022Qube Research & Technologies Ltd20,342$0.18M0.0%N/A0.088%
2/9/2022Alps Advisors Inc.26,662$0.23M0.0%N/A0.116%
2/3/2022Brighton Jones LLC14,145$0.12M0.0%N/A0.061%
2/1/2022Qube Research & Technologies Ltd20,342$0.18M0.0%N/A0.088%
1/28/2022Allspring Global Investments Holdings LLC26,675$0.23M0.0%N/A0.116%
1/25/2022Epiq Partners LLC18,646$0.16M0.1%N/A0.081%
12/10/2021Towercrest Capital Management50,500$0.62M0.1%N/A0.219%
11/15/2021First Manhattan Co.6,700$81K0.0%N/A0.034%
11/12/2021Geode Capital Management LLC117,916$1.44M0.0%+131.5%0.604%
11/9/2021BlackRock Inc.268,730$3.27M0.0%+7.0%1.377%
11/8/2021Trustcore Financial Services LLC13,407$0.16M0.0%N/A0.069%
11/8/2021Russell Investments Group Ltd.200,806$2.45M0.0%N/A1.029%
11/2/2021New York State Common Retirement Fund6,867$84K0.0%-49.9%0.035%
11/2/2021Victory Capital Management Inc.80,390$0.98M0.0%-28.7%0.412%
10/13/2021FNY Investment Advisers LLC5,377$65K0.0%N/A0.028%
8/17/2021Woodline Partners LP119,615$1.06M0.0%N/A0.537%
8/17/2021Zimmer Partners LP25,000$0.22M0.0%N/A0.112%
8/17/2021Kohlberg Kravis Roberts & Co. L.P.3,802,639$33.65M0.1%N/A17.071%
8/16/20215AM Venture Management LLC2,884,791$25.53M6.4%N/A12.950%
8/16/2021California State Teachers Retirement System7,464$66K0.0%N/A0.034%
8/16/2021venBio Partners LLC2,759,791$24.42M2.9%N/A12.389%
8/16/2021Pinz Capital Management LP6,188$55K0.0%N/A0.028%
8/16/2021Charles Schwab Investment Management Inc.11,413$0.10M0.0%N/A0.051%
8/16/2021State Street Corp46,298$0.41M0.0%N/A0.208%
8/13/2021Northern Trust Corp58,493$0.52M0.0%N/A0.263%
8/13/2021Geode Capital Management LLC50,942$0.45M0.0%N/A0.229%
8/13/2021Vanguard Group Inc.183,753$1.63M0.0%N/A0.825%
8/12/2021JPMorgan Chase & Co.6,653$59K0.0%N/A0.030%
8/11/2021BlackRock Inc.251,063$2.22M0.0%N/A1.127%
8/11/2021Deutsche Bank AG3,196$28K0.0%N/A0.014%
8/10/2021Norwest Venture Partners Xiv LP3,077,198$27.23M31.4%N/A13.814%
8/3/2021Victory Capital Management Inc.112,730$1M0.0%N/A0.506%
(Data available from 1/1/2016 forward)













IMPL Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of IMPL shares?

During the previous two years, 33 institutional investors and hedge funds held shares of Impel Pharmaceuticals. The most heavily invested institutionals were NVP Associates LLC ($11.54M), Vanguard Group Inc. ($3.39M), Russell Investments Group Ltd. ($2.45M), Point72 Asset Management L.P. ($1.80M), Opaleye Management Inc. ($1.35M), Millennium Management LLC ($1.34M), and Laurion Capital Management LP ($1.16M).Learn more on IMPL's institutional investors.

What percentage of Impel Pharmaceuticals stock is owned by institutional investors?

73.88% of Impel Pharmaceuticals stock is owned by institutional investors. Learn more on IMPL's institutional investor holdings.

Which institutional investors have been buying Impel Pharmaceuticals stock?

Of the 28 institutional investors that purchased Impel Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: NVP Associates LLC ($3.08M), Point72 Asset Management L.P. ($0.21M), Russell Investments Group Ltd. ($0.20M), DCF Advisers LLC ($0.18M), Opaleye Management Inc. ($0.14M), Millennium Management LLC ($0.14M), and Laurion Capital Management LP ($0.12M).

How much institutional buying is happening at Impel Pharmaceuticals?

Institutional investors have bought a total of 4,549,664 shares in the last 24 months. This purchase volume represents approximately $25.02M in transactions.

Which Impel Pharmaceuticals major shareholders have been selling company stock?

Of the 10 institutional investors that sold Impel Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: State Street Corp ($0.15M), DCF Advisers LLC ($79.54K), Northern Trust Corp ($39.77K), Victory Capital Management Inc. ($32.34K), Renaissance Technologies LLC ($16K), BlackRock Inc. ($9.41K), and Qube Research & Technologies Ltd ($8.48K).

How much institutional selling is happening at Impel Pharmaceuticals?

Institutional investors have sold a total of 349,107 shares in the last 24 months. This volume of shares sold represents approximately $2.55M in transactions.


This page (NASDAQ:IMPL) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -